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Abstract.  The expression of keratin  18 (K18)  is re- 
stricted in humans primarily to a variety of single 
layered or simple epithelia.  However, direct introduc- 
tion of a cloned K18 gene into cultured,  somatic cells 
by DNA transfection has been shown to result in the 
promiscuous expression of K18 even while the endoge- 
nous mouse form of K18 (Endo B) remains  silent.  To 
determine if the cloned K18 genomic DNA fragment 
contains sufficient information to be regulated ap- 
propriately when subjected to a  normal developmental 
environment,  and to determine if the cloned gene is 
expressed in diverse epithelia,  the K18 gene, including 
2.5 kb of 5' flanking sequence and 3.5  kb of 3' flank- 
ing sequence, has been introduced into the germ line 
of mice.  Mice from all three resulting K18 transgenic 
lines express the gene in an appropriate tissue-specific 
pattern that includes hepatocytes, simple epithelia of 
the intestinal  tract,  ductal cells of several glands and 
epithelial cells of the thymus.  No expression of K18 
was found in muscle, heart,  or in most of the brain 
even in mice carrying  18 copies of the K18 gene.  In 
most tissues, the level of K18 RNA was directly 
proportional to copy number and was as efficiently ex- 
pressed as the endogenous Endo B gene.  The K18 pro- 
tein was identified by both protein blotting methods 
and indirect immunofluorescence staining.  No patho- 
logical consequences of overexpression of the K18 
gene were observed. The cloned K18 gene appears to 
contain all cis-acting  DNA sequences necessary for 
appropriate expression.  In addition,  diverse epithelial 
cell types are able to express this  single human gene. 
I 
N vertebrates, the •20  different keratin  proteins repre- 
sent the largest group of intermediate  filament proteins. 
They are further subdivided into the generally smaller 
and more acidic type I keratins and the larger and more basic 
type II keratins (8, 46). Keratin  intermediate  filaments  are 
formed by the polymerization of type I and type II proteins, 
through the initial formation of a heterotypic dimer (17) and 
subsequently through tetrameric complexes (16, 43). In adult 
tissues, the different  keratins are expressed in a variety of 
epithelia  in tissue specific  patterns  that  generally include 
particular pairs of one type I and one type II keratin (8, 32). 
Keratin  18 (K18) appears to be the ancestral  type I keratin 
from which the other specialized members of the group have 
evolved (1). Endo B, the mouse form of K18, and its com- 
plementary partner Endo A (the mouse form of keratin  8) 
are the first intermediate  filament proteins to be expressed 
during mouse development. They are first detectable just be- 
fore the morula stage (7, 11, 12, 36) and are found in trophec- 
toderm at the blastocyst stage (5, 21, 36). In adults,  K18 is 
found primarily in a variety of simple epithelial although ex- 
ceptions occur (3, 29). In mice, there are five genes closely 
related to Endo B. Only one appears to be responsible for 
the expression of the protein. (20, 38, 50). However, South- 
ern hybridization experiments  under conditions  that do not 
detect  other  members  of the  intermediate  gene  family, 
identified over 20 sequences homologous to K18 in humans 
(38, 50). Thus,  it is possible that more than a single human 
K18 gene might be responsible for expression in different hu- 
man tissues. 
K18 appears to represent a class of genes that are more re- 
stricted in their tissue specificity  than constitutively  active 
metabolic functions but less restricted than very specialized 
differentiated products.  In somatic mouse cell lines, expres- 
sion of Endo B is transcriptionally  regulated  and inversely 
correlated with both a  methylated DNA state and  a  con- 
densed chromatin  state (38).  Somatic cell hybridization  ex- 
periments  have  implicated  cis-acting  negative  regulatory 
mechanisms in the control of Endo B and K18 expression 
(38). The observation that the characterized human K18 gene 
is capable of efficient expression when introduced directly 
into cultured fibroblastic  cells by DNA transfection,  even 
while  the  endogenous,  homologous  gene  remains  silent, 
reinforces  this  suggestion  (26).  The characteristic  of inap- 
propriate,  promiscuous expression after direct transfection 
has been observed for other intermediate  filament genes as 
well (22, 34, 42, 52). The results of studies using transgenic 
mice suggest that the flanking  regions of the vimentin and 
keratin  14 genes may contain the regulatory signals neces- 
sary for tissue-specific  expression of these intermediate  fila- 
ment genes (41, 52). However, recently an essential  regula- 
tory region has been identified  within the first intron of the 
K18 gene.  This enhancer element is activated  by c-fos and 
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rated a K18 construction that includes all available 5' and 3' 
flanking sequences as well as the first intron express a/3-ga- 
lactosidase reporter gene only in embryos but not in adult 
animals  (R.  Pedersen  and  R.  G.  Oshima,  unpublished 
results). This implies that additional regulatory elements re- 
side within the K18 gene. To determine  whether the 10-kb 
human genomic DNA  fragment  containing  the K18 gene 
has sufficient regulatory information to be appropriately ex- 
pressed when subjected to a normal developmental environ- 
ment, we have generated transgenic  mice carrying the K18 
gene. In this study, we show that the K18 gene is regulated 
appropriately in transgenic mice and thus appears to contain 
all necessary regulatory signals. In addition, diverse epithe- 
lia of these transgenic mice are capable of expressing the sin- 
gle cloned K18 gene. 
Materials and Methods 
Transgenic Mice 
The genomic fragment containing the KI8 gene was excised from the previ- 
ously characterized plasmid pGC1853 (26, 27) by digestion with Hind HI. 
The 10-kb fragment, at a DNA concentration of 0.5 ng/#l, was injected into 
the pronuclei of fertilized strain FVB/N mouse eggs and transferred to pseu- 
dopregnant strain CD-1  foster mothers.  These manipulations were per- 
formed by Ms. Jacqueline Avis using standard methods (19) (Transgenic 
Mouse Facility of the La Jolla, California Cancer Research Foundation). 
RNA, protein and histological analyses were performed on tissues dissected 
from F1 heterozygous  mice at '~6 wk.  The three founder K18 transgenic 
mice were assigned La Jolla Cancer Research Foundation animal identi- 
fication numbers 71, 56, and 59 and are referred to as K18TG1, KISTG2 and 
KIgTG3, respectively,  in the text. 
Nucleic Acids Analysis 
Tail DNAs from resulting progeny were screened by Southern hybridization 
or dot blot hybridization using the K18 eDNA (37) labeled by the random 
primer method (13) and nylon filters  (Zetaprobe; Bio-Rad  Laboratories, 
Richmond, CA). Final washes were performed at 65°C in 0.1  x  SSC and 
0.1%  SDS.  DNA concentrations were  determined fluorimetrically  (30). 
Gels used for Southern blot analysis were stained with ethidium bromide 
both before and after blotting to confirm that the same amount of DNA was 
loaded in each lane. For quantitative estimation of the number of K18 genes 
(19), multiple Southern blot and dot blot analyses were performed on multi- 
ple concentrations of transgenic animal DNAs.  Hybridization to bands de- 
tected in Southern blots were compared to those of dilutions of digested 
plasmid DNAs by densitometry.  Dot blot hybridization  was quantitated by 
liquid scintillation counting.  Estimations of copy number by the two meth- 
ods were in good agreement. 
Total RNA was isolated by the g~anidinium isothiocyanate-cesium chlo- 
ride method (6, 51). Tissues were frozen in liquid nitrogen immediately after 
dissection and were then homogenized' directly in guanidinium isothio- 
cyanate solutions. For Northern blots, RNAs were separated in agarose gels 
containing formaldehyde (31), transferred to nylon filters and hybridized at 
43°C with the random-primed K18 eDNA excised from plasmid sequences 
or a 1,287-bp fragment of the Endo B eDNA (45, 50) derived by digestion 
with Eco RV and Sal I. Final washes were at 70°C for 15 rain in 0.1 × SSC 
and 0.1% SDS. Dot blot analysis of RNA levels were quantitated by liquid 
scintillation counting. 
S1  nuclease protection experiments were performed as previously  de- 
scribed using a K18 probe of 471 nt that overlaps the 5' end of the first exon 
by 240 nt and an Endo B probe of 658 nt that protects a  196-nt fragment 
of Endo B RNA (26, 38).  Endo B mRNA levels were determined by den- 
sitometry of Endo B signals in comparison to standards of synthetic Endo B 
mRNA made by SP6  RNA polymerase transcription of the full length 
Endo B eDNA (45) subcloned into the SP64 plasmid. 
Protein Analysis 
Antibody detection of KI8 proteins was performed on tissue homogenates 
prepared by the method used for immunoprecipitation of Endo B (35). Dis- 
sected tissues where homogenized in 0.1% SDS, 10 mM Tris-HCl (pH 7.4), 
3 mM MgC12, 0.1 raM CaCI2, 0.5 filM PMSF,  1 mM N-ethylmaleimide, 
and 1:100 volume of aprofinin (Sigma Chemical Co., St. Louis, MO) solu- 
tion. The homogenates were treated with 5/tg/ml of protease-free  DNase I 
(40) for 5 rain. SDS and EDTA were added to final concentration of 0.5% 
and 10 mM, respectively, and the samples were heated to 100oc for 2 min. 
NP-40 detergent was added to a final concentration of 1% and the samples 
were centrifuged to remove insoluble debris. Protein concentration was de- 
termined by the method of Bradford (4) (Bio-Rad Laboratories) on dilutions 
of  the lysates. Equal amounts of  protein were resolved by gel electrophoresis 
in the  presence  of  SDS  and transferred  to  nitrocellulose filters  (49). 
Nonspeciflc  protein binding was blocked with 1% nonfat dried milk. K18 
was detected by reaction with the PKK3 monoclonal antibody (gift of Ismo 
Virtanen, University of Helsinki) directed against K18 (53)  followed by 
aikaline-phosphatase-conjngated anti-mouse IgG (Sigma Chemical Co.). 
Alkaline phospbatase activity was visualized by reaction with 5-bromo-4- 
chloro-3-indoly  phosphate  (175 #g/ml)  and nitroblue tetrazolium (340 
#g/ml) in 0.1 M Tds-HC1 (pH 9.5),  0.1 M NaC1, and 0.1 M MgCI2. 
Iramunofluorescence 
Tissues dissected from transgenic mice or their nontransgenic siblings were 
embedded in OCT compound and frozen  on dry ice.  Frozen sections  of 
8 #m were fixed in methanol at -20°C for 5 rain. For use with mouse mono- 
clonai antibodies the sections were treated with 0.1% H2SO4 and 0.5% 
KMnO4 for 20 s and rinsed in water for 2  rain to remove  endogenous 
mouse immunoglobulin  reaction (14). To detect K18, the dried sections were 
treated with the PKK3 mouse monoclonai antibody and FITC conjugated 
sheep anti-mouse IgG (Organon Tekniha-Cappel,  Malvem, PA) secondary 
antibody. PKK3 had no reaction against Endo B in either immunoituores- 
cence or immunoblot analysis. To detect Endo B, rabbit anti-endo B antise- 
rum (35) and rhodamine conjugated  goat anti-rabbit IgO (Orgenun Tek- 
nika-Cappel)  was used. Endo A was detected with the use of the TROMA1 
rat monoclonai antibody (5, 24) and fluorescein-coupled  goat anti-rat IgG. 
Results 
Identification of Kl8 Transgenic Mice 
The human K18 gene fragment used for microinjection  was 
10 kb containing  2.5 kb of 5' flanking sequences and 3.5 kb 
of 3' flanking sequences (Fig.  1). Dot blot and Southern blot 
analysis detected K18 sequences in five of 81 resulting mice. 
However, two of these positive mice were germ line mosaics 
and were not analyzed further. Southern analysis of the Barn 
HI digested DNA of the remaining  three mice, designated 
KI8TG1, K18TG2 and K18TG3, is shown in Fig.  1. All three 
mice retained the internal 1.7- and 0.9-kb Barn HI fragments 
characteristic of the K18 gene. With the high stringency con- 
ditions used for the experiment shown in Fig. 1, the gene for 
the endogenous mouse form of K18 (Endo B/~-1) was not de- 
tected.  Comparison of the intensity  of the  1.7- and 0.9-kb 
fragments of the transgenic mice with plasmid standards by 
both additional  Southern analysis  and quantitative dot blot 
analysis  (data not shown) indicated  the K18TG1, K18TG2, 
and K18TG3 mice carried 004, 6, and 18 copies of the K18 
gene, respectively.  The largest hybridizing  fragments of the 
three mice likely  represent the expected multiple  arrays of 
the two flanking portions of the injected gene that would be 
expected to be 7.4 kb (3.9-kb 5' fragment plus the 3.5-kb 3' 
fragment)  if the genes  were  integrated  in  the  commonly 
found head-to-tail  arrangement.  The bands unique to each 
transgenic mice between the 6.6-kb and 2.3-kb lambda DNA 
markers likely  represent terminal fragments of the expected 
tandem arrays of genes and indicate  that each of the three 
mice has integrated the K18 gene at different positions. Addi- 
tional analysis with a unique K18 gene probe located near the 
5' end of the 5' flanking sequence of the gene confirmed that 
each transgenic animal had retained the distal 5' flanking se- 
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tected. In addition, potential homozygous progeny, as deter- 
mined by hybridization analysis,  have been'derived from 
both the K18TG1 (12/55 progeny) and K18TG2 (1/9 progeny) 
lines of mice.  However, no homozygous animals were de- 
tected among 35 progeny of 4 matings from 2 different pairs 
of K1KIG3 heterozygotes. This suggests that either the ex- 
pression of 36 K18 genes, expected in homozygous K18TG3 
mice, is incompatible with normal development or that the 
insertion of  the transgenes have caused a lethal recessive mu- 
tation. 
Figure 1. Southern blot analysis of K18 genes in transgenic mice. 
Mouse tail DNA (5 #g) was digested with Barn HI, subjected to 
electrophoresis in an agarose gel, transferred to nylon membranes, 
hybridized to the K18 eDNA probe,  and exposed to x-ray film. 
DNAs from the transgenic mice are indicated in lanes 1-3 and non- 
transgenic mouse (N) DNA is shown in lane 6. Lane 4 represents 
,o20 lag of  the pGC1853 plasmid that contains the cloned K18 gene. 
Size markers (M) of Hind 111 digested lambda DNA are shown in 
lane 5 with the fragment sizes indicated at the left in kilobases. The 
1.7- and 0.9-kb fragments of the K18 gene are indicated on the left. 
A map of the K18 gene used for microinjection is shown below. 
Exons are indicated by solid regions. Hatched and open regions in- 
dicate intron and flanking sequences, respectively. Barn  HI (B) and 
Hind 11I (H) restriction enzyme sites are indicated. The sizes of  the 
two internal Barn HI fragments are indicated above the map in kilo- 
bases. The eDNA probe hybridizes to all exons. 
quences of the injected fragment. In K18TG3 mouse DNA 
(Fig. 1, lane 2) only the two largest fragments detected with 
the K18 cDNA probe also hybridized with the 5' flanking se- 
quence probe (data not shown). These results are consistent 
with a  single unique integration site for each of the trans- 
genic mice. 
Subsequent  breeding of the  founder transgenic  animals 
have resulted in normal numbers of males and females. The 
frequencies of transmission ranged from 30 to 70%  in in- 
dividual litters, consistent with single sites of integration. To 
KI8 thRlV,4 Expression in Transgenic Animals 
K18 RNA expression was detected in the adult tissues of all 
three transgenic lines. A comparison of  K18 RNA expression 
in various tissues of the K18TG1 transgenic line with the ex- 
pression of endogenous Endo B RNA is shown in Fig. 2. In 
nontransgenic siblings, the 1.5-kb Endo B mRNA was de- 
tected by Northern blot experiments in jejunum, liver, thy- 
mus, and cervix but not in heart, skeletal muscle, brain, or 
spleen (Fig. 2 A). Endo B transcripts detected by $1 nuclease 
analysis (Fig. 2 C) were found in similar abundance and in 
the same tissues of K18TG3 mice as normal nontransgenic 
mice. In other experiments and with longer exposures, Endo B 
RNA was detected in kidney tissues but always at very low 
levels (data not shown). Similarly, RNA from spleen occa- 
sionally provided a  barely  detectable signal.  In  contrast, 
Endo B RNA was not detected in muscle or heart even with 
very long exposures. 
Under hybridization conditions that did not detect the en- 
dogenous Endo B mRNA (Fig. 2 B), the 1.4-kb K18 mRNA 
was detected easily in RNAs from jejunum, liver, and thy- 
mus of K18TG1 mice by Northern blot analysis (Fig. 2 B, 
lanes 5, 7, and 10). The signal for K18 mRNA in cervix may 
not be visible after reproduction, but additional analysis con- 
firmed its presence (Fig. 2 D, lane 10, and Fig. 3 A). In con- 
trast to Endo B RNA in normal mice, the K18 RNA was rela- 
tively abundant in kidney and the amount of K18 RNA in thy- 
mus was lower than expected from the abundance of Endo 
B mRNA. S1 nuclease protection experiments confirmed rel- 
atively abundant K18 transcripts in the kidney of K18TG1 
mice (Fig. 2 D, lane 6) and relatively low amounts in the thy- 
mus (Fig. 2 D, lane 7).  K18RNA was barely detectable in 
RNA from the brains of KlgIG3 animals but not from K18"I'G1 
animals (data not shown). Lung tissue had barely detectable 
Endo B RNA (Fig. 2  C, lane 10) while all K18 transgenic 
mice expressed detectable amounts of K18 mRNA in this tis- 
sue (Fig. 2 D, lane//, and Fig. 3 A). The S1 nuclease protec- 
tion experiments indicated the K18 RNAs expressed in KlgIG1 
mice were initiated at the same position as authentic K18 
RNA (Fig. 2 D, lane/) (26). A summary of the expression 
of  K18 and Endo B RNAs, including additional data not shown, 
is presented in Table I. 
Overall, the qualitative, tissue specific expression of K18 
RNA in all three transgenic lines was very closely correlated 
with the expression of the endogenous Endo B RNA found 
in organs containing simple epithelial tissues. However, the 
relative level of  K18 expression differed from Endo B expres- 
sion in kidney, lung, and thymus. The discordance with the 
relative levels of  Endo B RNA expression in these permissive 
tissues appeared not to be due to particular integration sites 
of the K18 genes because each of the transgenic lines had the 
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ous tissues of nontransgenic (N) 
and  K18  transgenic  mouse  tis- 
sues. Abbreviations used for the 
different  tissues:  Jej,  jejunum; 
Spl,  spleen;  L/v,  liver;  Mus, 
skeletal  muscle;  K/d,  kidney; 
7by,  thymus;  Hea,  heart;  Bra, 
brain; Cer, cervix; Lun, lung. (A) 
Northern  blot  analysis  of non- 
tnmsge~ tissues for ~  B RNA 
expression.  Lane  1  contained 
,,o25  pg  of  synthetic  Endo  B 
mRNA made by SP6 RNA puly- 
merase tramcrit~on of the Endo B 
cDNA  (45)  subcloned  into  the 
SP64  plasmid.  The  remaining 
lanes received 10 ~,g of  total RNA 
of  the indicated  tissue. A random- 
primed 1,287-bp  fragment of the 
Endo B cDNA generated by di- 
gestion with Eco  RV  and  Sal I 
was used as the probe. (B) North- 
ern blot analysis of nontransgenic 
and K18TGI transgenic tissues of 
K18  mRNA  expression.  Each 
lane contained 10/~g of  total RNA 
except for lane 1  that contained 
50  pg  of synthetic K18  mRNA 
made  by  T7  RNA  polymerase 
transcription of K18 cDNA in the 
pK187  plasmid  (37).  The  filter 
was hybridized with the random- 
primed K18 cDNA free of plas- 
mid sequences.  (C)  S1  nuclease 
protection  analysis of Endo B RNA 
in tissues ofa KI  8'rG3 line mouse. 
10 t~g of RNA from the indicated 
tissue was hybridized with a 658 
nt  single-stranded  DNA  probe 
that protects 196 bp of the 5' end 
of Endo B mRNA. After $1 nu- 
clease digestion and acrylamide 
gel electrophoresis in  the  pres- 
ence of 8-M urea, the protected 
fragments were detected by au- 
toradiographic  exposure  of  the 
dried gel in the presence of an in- 
tensified  screen.  The  protected 
fragment seen in lanes 1, 3, 6, 9, 
and faintly inlanes 5 and 10 were 
the same size (~196 tat) as found 
for synthetic Endo B mRNA stan- 
dards  (not  shown).  (D)  SI  nu- 
clease protection analysis of K18 
RNA in tissues of a K18TG1 line 
mouse. The experiment was per- 
formed as for C  except that the 
K18 probe was 470  nt in length 
with a 240 m over~ with authen- 
tic K18 mRNA. Lane I  shows the 
migration  position  and  relative 
intensity resulting from 50 pg of 
synthetic K18 mRNA as described 
for B. 
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EndoB RNA*  KI8 RNA~  t  K18 prot§  EndoA prot[I 
Line¶  TG3  N  TG 1  TG2  TG3  TG3  TG3 
Stomach  + +  + + +  + 
Jejunum  + +  + +  + +  + +  + + +  + 
Colon  + +  + + + +  + 
Thymus  + +  + +  +  + +  + +  + 
Liver  + +  + +  + +  + +  + + + +  + 
Cervix  + +  +  +  + + +  + 
Vesicular gland  + +  +  +  + + +  + 
Salivary gland  +  + +  + 
Kidney  +  5:  + +  + + +  + + + +  + 
Lung  5:  +  + +  + + +  + 
Brain  -  -  -  +  + 
Spleen  -  -  -  +  +  - 
Muscle  ...... 
Heart  ...... 
Skin  +  +  +  - 
Tongue  +  + +  - 
Esophagus  + +  - 
++ 
+ 
+ 
++ 
+ 
+ 
++ 
++ 
+++ 
++ 
++ 
+++ 
++ 
++ 
++ 
+++ 
+ 
+ 
+ 
* S1  nuclease protection. 
S1, Northern  or dot blot. 
§ Perceived intensity of immunofluorescent staining with PKK3 antibody. 
II Perceived  intensity of immunofluorescent staining with TROMA1  antibody. 
¶ All animals used were "~6 wk old. N, normal;  TG1,  K18TG1;  TG2,  K18TG2; TG3,  K18TG3. 
same pattern of tissue specific expression (Fig.  3 A).  The 
level of expression in  lung,  kidney, jejunum,  cervix,  and 
liver appeared to correlate directly with copy number. Care- 
ful quantitation of the levels of K18 RNA in the livers of mice 
from the three transgenic lines ahd of Endo B in both non- 
transgenic and transgenic animals confirmed a linear rela- 
tionship between transgene copy number and K18 RNA ex- 
pression (Fig. 3 B). In addition, the expression of K18 RNA 
appears to have little or no effect on the level of Endo B RNA 
expression (Fig.  3 B, inset, and Fig.  2, A and B).  Thus in 
vivo, as in cultured cells (26), there appears to be no effect 
on  the  expression of K18  RNA  on  the  levels  of Endo  B 
mRNA.  Finally,  the  K18  gene  appears  to  be  at  least  as 
efficiently  expressed  in  liver  as  the  endogenous  Endo  B 
genes. Together, the pattern of tissue specific expression, the 
linear dependence of expression on copy number and the 
efficiency of expression indicate that the 10-kb K18 genomic 
fragment used for microinjection appears to contain most if 
not all of the regulatory signals necessary for normal and po- 
sition  independent  expression.  Quantitative  difference  in 
K18 RNA levels relative to Endo B RNA in some permissive 
organs appears to be a characteristic of K18 genomic frag- 
ment used for microinjection. 
KI8 Protein Expression and Immunolocalization 
To confirm the biological activity of the K18 mRNA detected 
in transgenic animals, whole tissue lysates of the K18TG3 
line were separated by electrophoresis, transferred to nitro- 
cellulose,  and probed with a monoclonal antibody, PKK3, 
that binds human K18 (53) but not Endo B. Fig. 4 shows that 
PKK3 reactive proteins of the  same mobility as authentic 
K18 were detected in thymus, liver, and jejunum of K1KIG3 
line transgenic mice but not in muscle or brain. However, the 
relative abundance of the protein in the three positive tissues 
did not correlate closely with the relative level of K18 RNA. 
For example, in the thymus of K18TG3 mice, relatively little 
K18 RNA was detected (Fig. 3 A). However, K18 protein was 
easily detectable in K18TG3 thymus (Fig. 4, lane 2). The dis- 
cordance between the level of K18 RNA and K18 protein is 
likely due to posttranslational mechanisms as noted in the 
Discussion. 
The tissues that express either Endo B or KI8 in transgenic 
animals are composed of multiple cell types. Immunofluores- 
cent localization was used to identify those cells of complex 
organs that expressed stable K18 protein. Fig. 5 shows repre- 
sentative results of immunofluorescent staining of K18TG3 
transgenic tissues with the PKK3 monoclonal antibody di- 
rected against K18.  Similar results were obtained with the 
CK5 monoclonal antibody that recognizes K18 (48) (data not 
shown).  All  nontransgenic  tissues  were negative with the 
PKK3 antibody. For comparison, nontransgenic tissues were 
stained with rabbit Endo B antiserum (Fig. 5, A, D, and G). 
The patterns of K18 expression in K18TG3 jejunum, kidney, 
and liver were very similar to nontransgenic tissues stained 
for Endo B expression. K18 was localized to the epithelial 
cells of  jejunum, kidney, colon, and vesicular gland (Fig. 5, 
B, E, K, and L). The pattern of kidney staining of the trans- 
genie mice was virtually indistinguishable from that of Endo B 
reaction in normal mice even though the level of K18 RNA 
in kidney appeared relatively higher than that for Endo  B 
(Figs. 2 and 3). The cells of kidney tubules, particularly the 
distal portions, were strongly reactive (Fig.  5, E, and data 
not shown). In the colon, the basement membranes and con- 
nective tissues did not react (Fig. 5, J and K). In liver, hepa- 
tocytes and bile ducts were positive for K18. In the thymus, 
staining was limited to the reticular cells but not thymocytes 
(Fig. 5, C) while in salivary glands, strong reaction with myo- 
epithelial cells was evident (Fig. 5, F). Finally, brain tissue 
was negative with the exception of the ependymal cell layer 
that lines ventricles (Fig. 5 I). The detection of K18 in the 
ependymal cells of the brain supports an earlier report of 
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tive levels of K18 RNA in differ- 
ent tissues of  three K18 transgenic 
mice. Duplicate aliquots of 10 #g 
of RNA from the  indicated  tis- 
sues  of  a  nontransgenic  (N) 
mouse,  or. the  transgenic  lines 
K1KI'GI  (1),  K18TG2 (2),  and 
K18TG3 (3) were denatured,  im- 
mobilized on a  nylon filter,  hy- 
bridized  to  the  32p-labeled KI8 
cDNA and  washed  under  strin- 
gent conditions.  Included on the 
same filter were varying amounts 
of synthetic  K18  mRNA (small 
panel)  diluted  in the presence of 
tRNA carrier. After fluorographic 
detection of the signal  shown  in 
A,  the  spots  were  excised  and 
quantitated  by liquid  scintillation 
counting.  The  amount  of  K18 
RNA found in liver samples  are 
plotted in B as a function of the 
number of K18 genes found in the 
different  lines of mice. The inset 
in B also includes the estimates of 
Endo B  RNA abundance in ali- 
quots of the same RNAs used in 
A as determined by S1  nuclease 
protection and densitometer  scan- 
ning  of  appropriately  exposed 
films relative to synthetic Endo B 
mRNA  as  standards  (data  not 
shown). 
keratin type epitopes expressed in these cells (15). No reac- 
tion was detectable in multiple samples of muscle and heart 
tissues (data not shown). At high magnification K18 staining 
appeared filamentous in positive tissues suggesting that K18 
had  complexed  with  an  endogenous type II keratin  (most 
likely Endo A) to form typical intermediate filament struc- 
tures  as  was previously  found in cultured  cells  (26).  The 
staining patterns of the tissues of K18TG1 and K18TG2 trans- 
genic mice were very similar or identical to those shown for 
K18TG3 mice.  However, the degree of reaction was clearly 
reduced in K18TG1  mice as might be expected because of 
the lower gene copy number and RNA levels.  Because the 
Endo B antiserum recognizes both Endo B and K18, it was 
not possible to localize Endo B independently of K18 in the 
transgenic mice.  The distribution  of K18 was compared to 
that of Endo A, the complementary type II keratin which is 
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tion of K18 protein in tissue 
homogenates of different tis- 
sues  from  a  line  K18TG3 
mouse.  Proteins  solubilized 
by  SDS  were  separated by 
acrylamide gel electrophore- 
sis in the presence of SDS, 
transferred  to  rtitr~dose 
and  reacted  with  the PKK3 
monoclonal antibody to K18. 
Antibody binding was visual- 
ized by the activity of alka- 
line phosphatase-coupled an- 
timouse IgG. 20 #g of protein 
was loaded in each lane. Lane 
I contained  a homogenate  from 
the  NT2  human  embryonal 
carcinoma cell line as a positive control. A homogenate of liver 
from a nontransgenic mouse (N, lane  7) did not react with the 
antibody. 
normally coexpressed with Endo B, by use of the TROMA1 
monoclonal antibody (5,  24).  The distribution of Endo A 
matched that of K18  in  all  transgenic  tissues  examined. 
A  summary of the expression of K18, Endo B RNA,  and 
Endo A protein is shown in Table I. Sections of  three stratified 
epithelial tissues of  K18TG3 mice (skin, tongue, and esopha- 
gus) did not have detectable reaction with either the PKK3 
or TROMA1 antibodies (except for weak reaction of  hair fol- 
licles in skin) even though K18 RNA was detectable in each 
of these tissues. 
Discussion 
The tissue-specific expression of K18 provides strong evi- 
dence that the cloned Klg gene contains all regulatory sig- 
nals necessary for tissue-specific expression provided the 
gene is exposed to a  normal developmental environment. 
Some of  the regulatory sequences of  the K18 gene are located 
within the gene as well as in its flanking regions. For exam- 
ple, the first intron of the K18 gene has been shown to have 
transcriptional enhancer activity that is dependent upon the 
interaction of  members of  the JUN and FOS families of  tran- 
scription factors (39). This provides one of several different 
ways of modulating the transcriptional activity of the gene 
and may be an important component of the restricted expres- 
sion of  the gene in very early embryonic cells. However, even 
the inclusion of the first intron and all available 5' and 3' 
flanking sequences is not sufficient to ensure the expression 
of a reporter gene in adult transgenic animals (R. Pedersen 
and R. G. Oshima, unpublished observations). This implies 
the existence of additional necessary regulatory sequences 
located within the body of the gene. It is interesting that the 
keratin 14 and neurofilament-L  genes that are regulated rela- 
tively correctly when introduced into transgenic mice (23, 
52),  share with KI8 the characteristic of promiscuous ex- 
pression upon direct transfection into cultured cells (22, 26, 
52).  Other genes that are inappropriately expressed after 
transfection into cell  lines but are  regulated correctly in 
transgenic mice include N-myc (55) and alpha 1-acid glyco- 
protein gene (9). In the cases of K18 and N-myc, stably trans- 
fected cell lines that contain only a few gene copies have been 
examined in addition to transiently transfected cells. Expres- 
sion in these permanent lines appears to rule out the possible 
titration of trans-acting  negative regulatory molecules  in 
transiently transfected cells that commonly contain many 
copies of the exogenous genes. Perhaps the general mecha- 
nism of restricted transcriptional accessibility that has been 
proposed as a component of K18 regulation (38) is also im- 
portant for other intermediate filament genes. 
The efficient expression of the K18 genes in the K18TG 
mice relative to the endogenous Endo B homologue suggests 
that at  least  for  some permissive  tissues,  regulatory se- 
quences necessary for appropriate quantitative expression 
are also included within the K18 genomic fragment. The lin- 
ear dependence of K18 RNA expression in liver upon the 
number of integrated K18 genes reinforces this conclusion 
and suggests that appropriate KI8 expression can be obtained 
independent of the integration site.  However, presently this 
conclusion is based on only a modest number of transgenic 
animals and additional studies are needed for confirmation. 
It may be of  interest that in a survey of  the K18 genomic frag- 
ment used in this study, we have found no evidence for sites 
that preferentially bind to the nuclear scaffold (J. Bode and 
R. Oshima, unpublished results; reference 2). Such nuclear 
DNA attachment sites have been implicated in the position 
independent expression of the chicken lysozyme gene (47). 
The expression of K18 in a large variety of organs of the 
transgenic mice described in this study is consistent with the 
view that only a single K18 gene may be responsible for ex- 
pression of the protein in the different tissues. However, we 
cannot exclude the possibility that other K18 genes may be 
active in humans in addition to the one that has been charac- 
terized. This is a significant point because of the large num- 
ber of K18 genes detectable within primate DNAs (38, 50). 
Many or all of the additional homologous human sequences 
may represent processed pseudo genes as found in the mouse 
(20,  38). 
There is significant quantitative discordance of K18 RNA 
levels with Endo B RNA levels in several permissive tissues. 
In comparison to Endo B RNA, K18 RNA was lower than 
expected in thymus and higher than expected in kidney and 
lung in all three K18 transgenic lines. This variation may be 
due to species-specific differences in the effectiveness  of  par- 
ticular regulatory sequences. Alternatively, it is possible that 
additional regulatory elements that function to modulate the 
level of  K18 RNA in particular tissues may be located outside 
of the cloned K18 genomic fragment. 
Comparison of the relative levels of K18 RNA in different 
organs to the level of K18 protein found in tissue homo- 
genates of the same organs by Western blot analysis or by 
the intensity of immunofluorescent staining indicated that 
the mRNA level was not a good indicator of  the level of  accu- 
mulated K18 or Endo B protein. This result is in contrast to 
the  results  of transgenic mice that express  the neurofila- 
ment-L  gene (23). It is likely due to a combination of the sta- 
bility of keratin intermediate filaments and the instability of 
K18 and Endo B proteins that are in excess of a complemen- 
tary type II keratin. In cultured ceils, K18 protein expressed 
either in the absence or in excess of  a complementary type II 
keratin is degraded rapidly (10, 25, 28). In addition, overex- 
pression of K18 does not lead to a compensatory increase in 
the  endogenous complementary mouse keratin,  Endo A. 
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ments in the IOglG mice suggests that Endo A is similarly 
independently  regulated  in vivo. Thus, the amount of KI8 
protein found in a particular tissue is likely the result of sev- 
eral processes including the rates of synthesis  of Endo A, 
Endo B, K18, and other keratin proteins,  the competition of 
all type I keratins for complementary type II keratin part- 
ners, the rate of degradation of excess K18, and the stability 
of the intermediate filaments containing K18. Such processes 
likely vary from tissue to tissue. These results reinforce the 
conclusion of studies with cultured ceils that the commonly 
found equal amounts of Endo B and Endo A or K18 and K8 
in simple epithelial cell types are not due to tight regulation 
of the RNA levels of the complementary keratins (28). 
The  posttranslational  modulation of K18  protein  levels 
may be a significant  component of the explanation  of why 
K18  RNA  was  found  in  two  stratified  epithelial  tissues 
(tongue and esophagus) but no apparent antibody  reaction 
could be detected in these tissues (Table I). Detection of K18 
RNA in a third stratified epithelium, K18TG3 skin, may be 
due to inclusion of hair follicles that have been shown to ex- 
press some K18 (18). However, the detection of Endo B RNA 
and K18 RNA in tongue and esophagus is consistent with the 
recent demonstration that both K18 and K8 RNAs are detect- 
able in certain  stratified epithelia  that previously had been 
considered negative for K18 (3) and may be significant to the 
observations that carcinomas derived from stratified epithe- 
lium commonly express simple epithelial keratins (32, 33, 44, 
54). The reason that K18 protein is not detected in these nor- 
mal tissues may involve the particular anti-K18 monoclonal 
antibody because significant differences  in the reaction of a 
few  tissues with different K18 antibodies  have been docu- 
mented (3). However, regardless of the reason that KI8 pro- 
tein is not detected  in these tissues, the presence of detect- 
able K18 RNA, at least in the K18TG3 line that carries the 
highest number of copies of the K18 gene, suggests that three 
different transcriptional  states of the K18 gene exist in the 
adult animal. In permissive tissues like liver and the epithelia 
of colon and jejunum, the gene is expressed efficiently.  In 
nonpermissive tissues (heart, skeletal muscle, and the brain 
exclusive of the ependymal cells of the ventricles)  the K18 
gene appears silent even in mice containing 18 copies of the 
gene. In a few tissues (esophagus, tongue, and perhaps skin) 
the K18 genes appear to be transcriptionally  active but very 
weakly  expressed. 
With the use of additional transgenic mice and pluripotent 
teratocarcinoma  cells it should be possible to identify those 
regulatory  elements  necessary  for the efficient  transcrip- 
tional activity of the K18 gene, its stable repression  in non- 
permissive tissues, and its apparent characteristic of position 
independent,  gene copy number dependent  expression. 
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